Discover and read the best of Twitter Threads about #nglfinechem

Most recents (3)

Get ready for a very High risk High return portfolio.
Suppose I am a kind of risk taker who is very greedy and wanna make very quick money in no time.
So, I would love to gamble with my hard earned money for quick bucks.
But in the process, I may lose every penny I invested (1/n)
Beware,this is not normal situation.
I am a financially illeterate person who never take any kind of risk in #stockmarket .
But as some of friends R eager for a high growth #portfolio,I was studying some companies where money can be made huge or may be doomed completely!(2/n)
This is neither an #Investment advice nor a #portfolio per se, this is an out of box experiment for a coward and financially illeterate person, that's me to step out of his comfort zone.
Study every company in detail before any investment decision or consult your advisor. (3/n)
Read 8 tweets
Cost leader in Animal Pharma
NGL Fine Chem ๐Ÿ•๐Ÿ•โ€๐Ÿฆบ๐Ÿถ
Like and Retweet for better reach !
@unseenvalue @punitbansal14

A Thread ๐Ÿงต

CMP - 2820

Topics Covered :
1. Company overview
2. Management
3. Business segments
4. Business strategy
5. Backward Integration
6. Revenue split
7. Products
8. Manufacturing facilities
9.R&D expenditure

1. Company overview
Established in 1981, NGL Fine Chem manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical products Image
They cater to various Indian and global companies with high quality and reliable products. They acquired Macrotech Polychem for โ‚น7Cr in 2019 as part of a backward integration strategy.
Read 21 tweets
An analysis of #Sequent - Indiaโ€™s largest Animal Health Company
Like and retweet for more learnings ๐Ÿถ๐Ÿ•
A thread!๐Ÿงต
1. Points covered :
2. Promoters and management
3. Company overview
4. Why is it different from human pharma
5. Opportunity size
6. Stability of business
7. FMCG like business
8. Barriers to entry
9. Manufacturing facilities
10. Summary of financials
11. Major acquisitions
12. Capex Details
13. Reduced Debt
14. Future Growth prospects
15. Valuation
Promoters and management
Carlyle Group - Private equity firm Carlyle Group acquired a majority stake in Sequent in 2020 and are the new promoters of the company. They have a lot of experience investing in the healthcare sector both in India and globally.
Read 34 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!